Home » Topics » BioWorld Science

BioWorld Science
RSS

European approval of Prevymis triggers milestone payment to AiCuris

Jan. 31, 2018

InnoCare Pharma divulges novel FGFR inhibitors for cancer

Jan. 31, 2018

Bayer identifies new muscarinic M2 receptor PAMs

Jan. 31, 2018

Chiesi Farmaceutici discloses new compounds for asthma

Jan. 31, 2018

Roche patents compounds for treating HBV infection

Jan. 31, 2018

suPAR is a novel prognostic marker for metastatic CRC patients undergoing resection

Jan. 31, 2018

Celgene updates milestones of fourth quarter 2017

Jan. 31, 2018

Corbus Pharmaceuticals receives award to support phase IIb study of lenabasum

Jan. 31, 2018

Artelo Biosciences to evaluate anticancer potential of drug from NEOMED Institute

Jan. 31, 2018

FDA gives orphan drug status to Dauntless Pharmaceuticals' DP-1038 for acromegaly

Jan. 31, 2018

Popular Stories

NIH changes set industry up for workforce, ideas drought
BioWorld
On March 1, 2025, former NIH director Francis Collins’ announced that he had fully resigned from the NIH, where he continued to lead a laboratory after his...
Today's news in brief
BioWorld
BioWorld briefs for March 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for March 14, 2025
At CROI, HIV cure trials raise hopes for broader applicability
BioWorld
At the 2025 meeting of the Conference on Retroviruses and Opportunistic Infections (CROI) it was the best of times, it was the worst of times. On the first full...
Hummingbird migrates ADCs, tech to newco Callio’s $187M debut
BioWorld
Antibody-drug conjugate (ADC)-focused Callio Therapeutics debuted on March 3 with the closing of a $187 million series A financing round based on cancer drug...